+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
ONESOURCE

OneSource Specialty Pharma Share Price

₹1,548.80 +11 (0.72%)
46.53% Gain from 52W Low

07 Sep, 2026 2:41 PM (IST)

OneSource Specialty Pharma live price: ₹1,548.80. It opened at ₹1,553 vs previous close ₹1,538; intraday high/low: ₹1,573/₹1,530. The 50 & 200 DMA stand at ₹1,586.80/₹1,618.50.

OneSource Specialty Pharma Performance

  • Today's Low
  • ₹1,530
  • Today's High
  • ₹1,573
  • 52 Week Low
  • ₹1,057
  • 52 Week High
  • ₹1,925
  • Open Price₹1,553
  • Previous Close₹1,538
  • Volume98,434
  • 50 DMA₹1,586.80
  • 100 DMA₹1,605.70
  • 200 DMA₹1,618.50

OneSource Specialty Pharma Chart

Investment Returns

  • Over 1 Month -0.53%
  • Over 3 Month -13.46%
  • Over 6 Month + 4.61%
  • Over 1 Year -17.32%

Smart Investing Starts Here Start SIP with OneSource Specialty Pharma for Steady Growth!

Invest Now

OneSource Specialty Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -365.3
  • PEG Ratio
  • 1.3
  • Market Cap Cr
  • 17,761
  • P/B Ratio
  • 3
  • Average True Range
  • 50.3
  • EPS
  • -4.2
  • Dividend Yield
  • 0
  • MACD Signal
  • -18.3
  • RSI
  • 46.22
  • MFI
  • 50.49

Latest Stock News Updates

Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of the investor presentation

Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper advertisement confirming the dispatch of the notice convening the 19th AGM of the Company and Remote e-voting

Onesource Specialty Pharma Ltd - 544292 - Notice Of The 19Th AGM Dated September 23, 2026

Intimation of the Notice of the 19th AGM (2nd AGM after listing), to be held on September 23, 2026 at 5:00 pm through Video Conferencing or other Audio Visual Means

OneSource Specialty Pharma Financials

OneSource Specialty Pharma Technicals

EMA & SMA

Current Price
₹1,548.80
+ 11 (0.72%)
pointer
  • Bearish Moving Average 10
  • Bullish Moving Average 6
  • 20 Day
  • ₹1,548.90
  • 50 Day
  • ₹1,586.80
  • 100 Day
  • ₹1,605.70
  • 200 Day
  • ₹1,618.50

Resistance and Support

1550.6 Pivot Speed
  • R3 1,651.00
  • R2 1,623.70
  • R1 1,580.70
  • S1 1,510.40
  • S2 1,483.10
  • S3 1,440.10

OneSource Specialty Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-07-24 Quarterly Results
2026-05-13 Audited Results
2026-01-23 Quarterly Results
2025-11-11 Quarterly Results
2025-08-04 Quarterly Results

OneSource Specialty Pharma Shareholding Pattern

30.48%
26.95%
19.19%
12.98%
10.39%

About OneSource Specialty Pharma

OneSource Specialty Pharma is engaged in the research, development, manufacture and commercialisation of biological drug products in various injectable formats. OneSource also offers end-to-end Contract Development and Manufacturing Operations services across all phases of pre-clinical and clinical development and commercial supply of biologics. View More
  • NSE Symbol
  • ONESOURCE
  • BSE Symbol
  • 544292
  • Executive Director,Managing Director,Chief Executive Officer
  • Neeraj Sharma
  • ISIN
  • INE013P01021

Similar Stocks to OneSource Specialty Pharma

OneSource Specialty Pharma FAQs

OneSource Specialty Pharma share price is ₹1,548 As on 07 September, 2026 | 14:29

The Market Cap of OneSource Specialty Pharma is ₹17760.5 Cr As on 07 September, 2026 | 14:29

The P/E ratio of OneSource Specialty Pharma is -365.3 As on 07 September, 2026 | 14:29

The PB ratio of OneSource Specialty Pharma is 3 As on 07 September, 2026 | 14:29

The 52 week High & Low of OneSource Specialty Pharma is ₹1925/₹1057 respectively As on 07 September, 2026 | 14:29

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23